Guidelines for treating movement problems in people in the early stages of Parkinson’s disease have been updated. The new treatment recommendations from the American Academy of Neurology (AAN) focus on dopaminergic medications, which increase dopamine levels or mimic dopamine effects. Parkinson’s is a movement disorder that occurs when nerve cells in the brain fail to…  read on >  read on >

Neurologists must make sure Alzheimer’s patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement that includes ethical guidelines. “Aducanumab is not a cure for Alzheimer’s disease, yet since it has been approved by the [U.S. Food and Drug…  read on >  read on >

Most people know that sun-sourced vitamin D is good for their bones. So could avoiding the sun to reduce skin cancer risk weaken your bones? A new study brings a reassuring answer: “Sun-protective” behavior — wearing long sleeves, seeking shade or using sunscreen — “was not associated with decreased bone mineral density or increased risk…  read on >  read on >

For decades, doctors have struggled with the fact that the benefit of any blood-thinning pill came with the added risk of excess bleeding. Now, an experimental anti-clotting pill called milvexian has been found to be effective in patients who had knee replacement surgery — without adding any excess risk for bleeding. The study focused on…  read on >  read on >

Ten people in seven states have been sickened in an E. coli outbreak linked to baby spinach, the U.S. Centers for Disease Control and Prevention said Monday. The agency said people should not eat, sell or serve Josie’s Organics prepackaged baby spinach that has a “best by” date of 10/23/2021 and was sold nationwide. Cases…  read on >  read on >